Folic Acid Supplement Prevents Phenytoin-Induced Gingival Hyperplasia
Researchers at the Division of Pediatric Neurology, Neurosciences Centre, New Delhi, India, performed a randomized, double-blind, placebo-controlled 6-month trial of oral folic acid supplement (0.5 mg/day) in children aged 6-15 years treated with phenytoin for epilepsy.
Furkejuvvon:
| Váldodahkki: | |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Pediatric Neurology Briefs Publishers
2011-05-01
|
| Ráidu: | Pediatric Neurology Briefs |
| Fáttát: | |
| Liŋkkat: | https://www.pediatricneurologybriefs.com/articles/632 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|